A Randomized, Double Blind, Placebo-Controlled, Parallel Group, Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain
Latest Information Update: 09 Aug 2022
At a glance
- Drugs MR-107A-01 (Primary)
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors Mylan
- 12 Jan 2021 Status changed from recruiting to completed.
- 22 Oct 2020 Status changed from not yet recruiting to recruiting.
- 07 Oct 2020 New trial record